Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024;30(4):244-247.
doi: 10.5114/pedm.2024.146687.

Medullary thyroid carcinoma in a 6-year-old boy with previous Langerhans cell histiocytosis presenting high level of pro-calcitonin

Affiliations
Case Reports

Medullary thyroid carcinoma in a 6-year-old boy with previous Langerhans cell histiocytosis presenting high level of pro-calcitonin

Gerdi Tuli et al. Pediatr Endocrinol Diabetes Metab. 2024.

Abstract

Objectives: To describe medullary thyroid cancer (MTC) onset in a boy affected previously by Langerhans cell histiocytosis (LCH) and review the literature for other reports of this association.

Case presentation: A 6-year-old boy was treated for LCH diagnosis when he was 4 years old. After treatment, a rise in procalcitonin levels was observed (2.36-2.78 ng/ml) initially interpreted as inflammatory response. Further procalcitonin increase (4.61 ng/ml) with cervical lymphadenopathy and no infective focus was suspicious of thyroid involvement, confirmed by ultrasound, serum calcitonin, and cytological diagnosis. Total thyroidectomy with bilateral lymph node exeresis was performed. RET gene analysis revealed p.Met918Thr mutation. No association between the previous LCH and MTC had been identified to date.

Conclusions: MTC is a rare condition in childhood presenting with an aggressive behaviour. It becomes crucial to increase the awareness of its features and anticipate diagnosis. Therefore, persistent high levels of pro-calcitonin without infective/inflammatory focus should lead to suspicion of thyroid involvement.

Keywords: Langerhans cell histiocytosis.; calcitonin; medullary thyroid cancer; paediatric age; procalcitonin.

PubMed Disclaimer

Conflict of interest statement

not declared.

References

    1. Lebbink CA, Links TP, Czarniecka A, et al. . 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J 2022; 11: e220146. doi:10.1530/ETJ-22-0146. - DOI - PMC - PubMed
    1. Wells SA Jr, Asa SL, Dralle H, et al. .; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 2015; 25: 567–610. doi: 10.1089/thy.2014.0335. - DOI - PMC - PubMed
    1. Graves CE, Gosnell JE. Medullary Thyroid Carcinoma in Children. Semin Pediatr Surg 2020; 29: 150921. doi: 10.1016/j.sempedsurg.2020.150921. - DOI - PubMed
    1. Eckelt F, Pfaeffle R, Kiess W, Kratzsch J. Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents. J Pediatr Endocrinol Metab 2021; 34: 1491–1504. doi: 10.1515/jpem-2021-0163. - DOI - PubMed
    1. Giraudet AL, Vanel D, Leboulleux S, et al. . Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab 2007; 92: 4185–4190. doi: 10.1210/jc.2007-1211. - DOI - PubMed

Publication types

Supplementary concepts